Search Results
Sandip Patel, MD, on the role of immunotherapies when treating cancer near end of life
Sandip Patel, MD, discusses some solutions for managing toxicities associated with immunotherapies
Sandip Patel, MD, describes the prominent safety challenges with administration of immunotherapies
Sandip Patel, MD, on identifying patient types likely to experience immune-related adverse events
Sandip Patel, MD, considers immunotherapy combinations and the likelihood of severe adverse events
Dr. Patel on Primary and Adaptive Resistance to Immunotherapy in NSCLC
Sandip Patel, MD, on treatment in the 2nd line setting following PD-L1 targeting agents
Novel Cancer Immunotherapeutics: New Targets, New Combinations - Sandip Patel, UCSD
Sandip Patel, MD: Comprehensive Genomic Profiling
Copy of Dr. Patel on Novel Agents for Patients With NSCLC
Dr. Patel on Novel Agents for Patients With NSCLC
Gut Health, Diet, and Cancer
